Proton magnetic resonance spectroscopy in alcohol use disorders: A potential new endophenotype?

Alcoholism: Clinical and Experimental Research

Volumn 32, Issue 7, 2008, Pages 1146-1158

  Meyerhoff, Dieter J ^a,b   Durazzo, Timothy C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brain; Endophenotype; Genetics; Magnetic Resonance Spectroscopy; Neuroimaging

Indexed keywords

APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; MU OPIATE RECEPTOR; DIAGNOSTIC AGENT; PROTON;

ALCOHOL USE DISORDER; ALCOHOLISM; ARTICLE; COGNITION; COHORT ANALYSIS; GENE FUNCTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOMICS; HEREDITY; HUMAN; NEUROBIOLOGY; NEUROIMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHIATRY; BRAIN; CLASSIFICATION; GENETICS; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW;

ALCOHOL-RELATED DISORDERS; BRAIN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; PROTONS;

EID: 54749123683     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2008.00695.x     Document Type: Article

References (141)

1. Adinoff B, Kramer GL, Petty F (1995) Levels of gamma-aminobutyric acid in cerebrospinal fluid and plasma during alcohol withdrawal. Psychiatry Res 59:137-144.
2. Baler RD, Volkow ND (2006) Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med 12:559-566.
3. Barker PB, Breiter SN, Soher BJ, Chathamn JC, Forder JR, Samphilipo MA, Magee CA, Anderson JA (1994) Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 32:157-163.
4. Barr CS, Schwandt M, Lindell SG, Chen SA, Goldman D, Suomi SJ, Higley JD, Heilig M (2007) Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry 64:369-376.
5. Barrett SP, Tichauer M, Leyton M, Pihl RO (2006) Nicotine increases alcohol self-administration in non-dependent male smokers. Drug Alcohol Depend 81:197-204.
6. Bartres-Faz D, Junque C, Clemente IC, Lopez-Alomar A, Bargallo N, Mercader JM, Moral P (2002) Relationship among (1)H-magnetic resonance spectroscopy, brain volumetry and genetic polymorphisms in humans with memory impairment. Neurosci Lett 327:177-180.
7. Bartsch AJ, Homola G, Biller A, Smith SM, Weijers HG, Wiesbeck GA, Jenkinson M, De Stefano N, Solymosi L, Bendszus M (2007) Manifestations of early brain recovery associated with abstinence from alcoholism. Brain 130:36-47.
8. Bates TE, Strangward M, Keelan J, Davey GP, Munro PM, Clark JB (1996) Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 7:1397-1400.
9. Begleiter H, Porjesz B (1999) What is inherited in the predisposition toward alcoholism? A proposed model. Alcohol Clin Exp Res 23:1125-1135.
10. Bendszus M, Weijers HG, Wiesbeck G, Warmuth-Metz M, Bartsch AJ, Engels S, Boning J, Solymosi L (2001) Sequential MR imaging and proton MR spectroscopy in patients who underwent recent detoxification for chronic alcoholism: correlation with clinical and neuropsychological data. AJNR Am J Neuroradiol 22:1926-1932.
11. Berman SM, Whipple SC, Fitch RJ, Noble EP (1993) P3 in young boys as a predictor of adolescent substance use. Alcohol 10:69-76.
12. Bierut LJ, Rice JP, Goate A, Hinrichs AL, Saccone NL, Foroud T, Edenberg HJ, Cloninger CR, Begleiter H, Conneally PM, Crowe RR, Hesselbrock V, Li TK, Nurnberger JI Jr, Porjesz B, Schuckit MA, Reich T (2004) A geno-mic scan for habitual smoking in families of alcoholics: common and specific genetic factors in substance dependence. Am J Med Genet A 124:19-27.
13. Birken DL, Oldendorf WH (1989) N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 13:23-31.
14. Bleich S, Degner D, Sperling W, Bonsch D, Thurauf N, Kornhuber J (2004) Homocysteine as a neurotoxin in chronic alcoholism. Prog Neuropsycho-pharmacol Biol Psychiatry 28:453-464.
15. Bleich S, Wilhelm J, Graesel E, Degner D, Sperling W, Rossner V, Javaheri-pour K, Kornhuber J (2003) Apolipoprotein E epsilon 4 is associated with hippocampal volume reduction in females with alcoholism. J Neural Transm 110:40 1-411.
16. Bottlender M, Soyka M (2005) Efficacy of an intensive outpatient rehabilitation program in alcoholism: predictors of outcome 6 months after treatment. Eur Addict Res 11:132-137.
17. Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289-298.
18. Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE (2003) The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology 60:1077-1081.
19. Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR, Verchinski BA, Meyer-Lindenberg A, Balkissoon R, Kolachana B, Goldberg TE, Weinberger DR (2005) Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci US A 102:8627-8632.
20. Cardenas VA, Studholme C, Meyerhoff DJ, Song E, Weiner MW (2005) Chronic active heavy drinking and family history of problem drinking modulate regional brain tissue volumes. Psychiatry Res 138:115-130.
21. Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL, Alexander GG (2004) Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 62:1990-1995.
22. Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science 236:410-416.
23. Cotman CW, Berchtold NC (2002) Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25:295-301.
24. Cummings JL (1998) Frontal-subcortical circuits and human behavior. J Psy-chosom Res 44:627-628.
25. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, Pena Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW (2007) Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315:1267-1270.
26. Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Conde F, Bloch G, Hantraye P (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochon-drial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab 20:789-799.
27. De Stefano N, Matthews PM, Arnold DL (1995) Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 34:721-727.
28. Demougeot C, Garnier P, Mossiat C, Bertrand N, Giroud M, Beley A, Marie C (2001) N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 77:408-415.
29. Drejer K, Theilgaard A, Teasdale TW, Schulsinger F, Goodwin DW (1985) A prospective study of young men at high risk for alcoholism: neuropsycho-logical assessment. Alcohol Clin Exp Res 9:498-502.
30. Drobes DJ (2002) Cue reactivity in alcohol and tobacco dependence. Alcohol Clin Exp Res 26:1928-1929.
31. Durazzo TC, Cardenas VA, Studholme C, Weiner MW, Meyerhoff DJ (2007a) Non-treatment-seeking heavy drinkers: Effects of chronic cigarette smoking on brain structure. Drug Alcohol Depend 87:76-82.
32. Durazzo TC, Gazdzinski S, Banys P, Meyerhoff DJ (2004) Cigarette smoking exacerbates chronic alcohol-induced brain damage: a preliminary metabolite imaging study. Alcohol Clin Exp Res 28:1849-1860.
33. Durazzo TC, Gazdzinski S, Banys P, Meyerhoff DJ (2006) Brain metabolite concentrations and neurocognition during short-term recovery from alcohol dependence: Preliminary evidence of the effects of concurrent chronic cigarette smoking. Alc Clin Exp Research 30:539-551.
34. Durazzo TC, Gazdzinski S, Meyerhoff DJ (2007b) The neurobiological and neurocognitive consequences of chronic cigarette smoking in alcohol use disorders. Alcohol Alcohol 42:174-185.
35. Durazzo TC, Meyerhoff DJ (2007) Neurobiological and neurocognitive effects of chronic cigarette smoking and alcoholism. Front Biosci 12:4079-4100.
36. Durazzo TC, Rothlind JC, Cardenas VA, Studholme C, Weiner MW, Meyerhoff DJ (2007c) Chronic cigarette smoking and heavy drinking in human immunodeficiency virus: consequences for neurocognition and brain morphology. Alcohol 41:489-501.
37. Durazzo TC, Rothlind JC, Gazdzinski S, Banys P, Meyerhoff DJ (2007d) Chronic smoking is associated with differential neurocognitive recovery in abstinent alcoholic patients: a preliminary investigation. Alcohol Clin Exp Res 31:1114-1127.
38. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98:6917-6922.
39. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269.
40. Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, Kleinman JE, Weinberger DR (2004) Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 101:12604-12609.
41. Ende G, Welzel H, Walter S, Weber-Fahr W, Diehl A, Hermann D, Heinz A, Mann K (2005) Monitoring the effects of chronic alcohol consumption and abstinence on brain metabolism: a longitudinal proton magnetic resonance spectroscopy study. Biol Psychiatry 58:974-980.
42. Enoch MA, Goldman D (2001) The genetics of alcoholism and alcohol abuse. Curr Psychiatry Rep 3:144-151.
43. Enoch MA, Schuckit MA, Johnson BA, Goldman D (2003) Genetics of alcoholism using intermediate phenotypes. Alcohol Clin Exp Res 27:169-176.
44. Fein G, Di Sclafani V, Finn P, Scheiner DL (2007) Sub-diagnostic psychiatric comorbidity in alcoholics. Drug Alcohol Depend 87:139-145.
45. Fein G, Meyerhoff DJ, Di Sclafani V, Ezekiel F, Poole N, MacKay S, Dillon WP, Constans J-M, Weiner MW (1994) 1H Magnetic Resonance Spectro-scopic Imaging Separates Neuronal From Glial Changes in Alcohol-Related Brain Atrophy. Chapter in NIAAA Research Monograph No. 27/Alcohol and Glial Cells. pp 227-241.
46. Ferguson KJ, MacLullich AM, Marshall I, Deary IJ, Starr JM, Seckl JR, Wardlaw JM (2002) Magnetic resonance spectroscopy and cognitive function in healthy elderly men. Brain 125:2743-2749.
47. Flatscher-Bader T, Zuvela N, Landis N, Wilce PA (2008) Smoking and alcoholism target genes associated with plasticity and glutamate transmission in the human ventral tegmental area. Hum Mol Genet 17:38-51.
48. Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schule C, Zwanzger P, Engel RR, Rupprecht R, Bondy B, Reiser M, Moller HJ (2004) Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry 61:177-183.
49. Frodl T, Schule C, Schmitt G, Born C, Baghai T, Zill P, Bottlender R, Rupprecht R, Bondy B, Reiser M, Moller HJ, Meisenzahl EM (2007) Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 64:410-416.
50. Gallinat J, Lang UE, Jacobsen LK, Bajbouj M, Kalus P, von Haebler D, Seifert F, Schubert F (2007) Abnormal hippocampal neurochemistry in smokers: evidence from proton magnetic resonance spectroscopy at 3 T. J Clin Psychopharmacol 27:80-84.
51. Gallinat J, Strohle A, Lang UE, Bajbouj M, Kalus P, Montag C, Seifert F, Wernicke C, Rommelspacher H, Rinneberg H, Schubert F (2005) Association of human hippocampal neurochemistry, serotonin transporter genetic variation, and anxiety. Neuroimage 26:123-131.
52. Gazdzinski S, Durazzo TC, Yeh PH, Hardin D, Banys P, Meyerhoff DJ (2008a) Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alcoholics. Psychiatry Res 162:133-145.
53. Gazdzinski S, Durazzo TC, Yeh PH, Hardin D, Meyerhoff DJ (2008b) Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alcoholics. Psychiatry Res 162:133-145.
54. Goldberg TE, Weinberger DR (2004) Genes and the parsing of cognitive processes. Trends Cogn Sci 8:325-335.
55. Hariri AR, Weinberger DR (2003) Imaging genomics. Br Med Bull 65:259-270.
56. Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 64:830-842.
57. Hill SY, Steinhauer SR (1993) Assessment of prepubertal and postpubertal boys and girls at risk for developing alcoholism with P300 from a visual discrimination task. J Stud Alcohol 54:350-358.
58. Hines LM, Ray L, Hutchison K, Tabakoff B (2005) Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci 7:153-163.
59. Ho BC, Andreasen NC, Dawson JD, Wassink TH (2007) Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 164:1890-1899.
60. Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH (2006) Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 63:731-740.
61. Ho BC, Wassink TH, O'Leary DS, Sheffield VC, Andreasen NC (2005) Cate-chol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry 10:229.
62. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815-826.
63. Hugg JW, Kuzniecky RI, Gilliam FG, Morawetz RB, Faught RE, Hethering-ton HP (1996) Normalization of contralateral metabolic function following temporal lobectomy demonstrated by h-1 magnetic resonance spectroscopic imaging. Ann Neurol 40:236-239.
64. Hughes J (2002) Do smokers with current or past alcoholism need different or more intensive treatment? Alcohol Clin Exp Res 26:1934-1935.
65. Hurt RD, Eberman KM, Croghan IT, Offord KP, Davis LJ Jr, Morse RM, Palmen MA, Bruce BK (1994) Nicotine dependence treatment during inpa-tient treatment for other addictions: a prospective intervention trial. Alcohol Clin Exp Res 18:867-872.
66. Hutchison KE, McGeary J, Smolen A, Bryan A, Swift RM (2002) The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychol 21:139-146.
67. Jagannathan NR, Desai NG, Raghunathan P (1996) Brain metabolite changes in alcoholism: An in vivo proton magnetic resonance spectroscopy (MRS) study. Magn Reson Imaging 14:553-557.
68. Jorm AF, Mather KA, Butterworth P, Anstey KJ, Christensen H, Easteal S (2007) APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology 21:1-8.
69. Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:1403-1413.
70. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC (1997) Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 54:313-321.
71. Kranzler HR, Rosenthal RN (2003) Dual diagnosis: alcoholism and co-morbid psychiatric disorders. Am J Addict 12(Suppl 1):S26-S40.
72. Kremerskothen J, Barnekow A (2000) Human activity-regulated cytoskeleton-associated gene (ARC) maps to chromosome 8q24. Chromosome Res 8:655.
73. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
74. Le AD, Li Z, Funk D, Shram M, Li TK, Shaham Y (2006) Increased vulnerability to nicotine self-administration and relapse in alcohol-naive offspring of rats selectively bred for high alcohol intake. J Neurosci 26:1872-1879.
75. Le AD, Wang A, Harding S, Juzytsch W, Shaham Y (2003) Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats. Psycho-pharmacology (Berl) 168:216-221.
76. Li CY, Mao X, Wei L (2008) Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 4:e2.
77. Lin A, Ross BD, Harris K, Wong W (2005) Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making. NeuroRx 2:197-214.
78. Lipsky RH, Marini AM (2007) Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann N Y Acad Sci 1122:130-143.
79. Lipsky RH, Sparling MB, Ryan LM, Xu K, Salazar AM, Goldman D, Warden DL (2005) Association of COMT Val158Met genotype with executive functioning following traumatic brain injury. J Neuropsychiatry Clin Neurosci 17:465-471.
80. Madden PA, Heath AC (2002) Shared genetic vulnerability in alcohol and cigarette use and dependence. Alcohol Clin Exp Res 26:1919-1921.
81. Marenco S, Steele SU, Egan MF, Goldberg TE, Straub RE, Sharrief AZ, Weinberger DR (2006) Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex. Am J Psychiatry 163:740-742.
82. Markou A, Paterson NE, Semenova S (2004) Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation. Ann N Y Acad Sci 1025:491-503.
83. Martin PR, Gibbs SJ, Nimmerrichter AA, Riddle WR, Welch LW, Willcott MR (1995) Brain proton magnetic resonance spectroscopy studies in recently abstinent alcoholics. Alcohol Clin Exp Res 19:1078-1082.
84. Mason GF, Petrakis IL, de Graaf RA, Gueorguieva R, Guidone E, Coric V, Epperson CN, Rothman DL, Krystal JH (2006) Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry 59:85-93.
85. McEwen BS, Magarinos AM (1997) Stress effects on morphology and function of the hippocampus. Ann N Y Acad Sci 821:271-284.
86. McFarland K, Lapish CC, Kalivas PW (2003) Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23:3531-3537.
87. McGeary JE, Monti PM, Rohsenow DJ, Tidey J, Swift R, Miranda R Jr (2006) Genetic moderators of naltrexone's effects on alcohol cue reactivity. Alcohol Clin Exp Res 30:1288-1296.
88. Mega MS, Cummings JL (1994) Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 6:358-370.
89. Meyerhoff D, Blumenfeld R, Truran D, Lindgren J, Flenniken D, Cardenas V, Chao LL, Rothlind J, Studholme C, Weiner H (2004) Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites. Alcohol Clin Exp Res 28:650-661.
90. Meyerhoff DJ, Tizabi Y, Staley JK, Durazzo TC, Glass JM, Nixon SJ (2006) Smoking comorbidity in alcoholism: neurobiological and neurocognitive consequences. Alc Clin Exp Research 30:253-264.
91. Miksys S, Lerman C, Shields PG, Mash DC, Tyndale RF (2003) Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology 45:122-132.
92. Miller BL, Chang L, Booth R, Ernst T, Cornford M, Nikas D, McBride D, Jenden DJ (1996) In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 58:1929-1935.
93. Moffett JR, Namboodiri MA, Cangro CB, Neale JH (1991) Immunohisto-chemical localization of N-acetylaspartate in rat brain. Neuroreport 2:131-134.
94. Moss HB, Chen CM, Yi HY (2007) Subtypes of alcohol dependence in a nationally representative sample. Drug Alcohol Depend 91:149-158.
95. Narahashi T, Soderpalm B, Ericson M, Olausson P, Engel JA, Zhang X, Nordberg A, Marszalec W, Aistrup GL, Schmidt LG, Kalouti U, Smolka M, Hedlund L (2001) Mechanisms of alcohol-nicotine interactions: alcoholics versus smokers. Alcohol Clin Exp Res 25(5 Suppl ISBRA):152S-156S.
96. Newlin DB, Thomson JB (1999) Chronic tolerance and sensitization to alcohol in sons of alcoholics: II. Replication and reanalysis. Exp Clin Psycho-pharmacol 7:234-243.
97. O'Hara R, Schroder CM, Mahadevan R, Schatzberg AF, Lindley S, Fox S, Weiner M, Kraemer HC, Noda A, Lin X, Gray HL, Hallmayer JF (2007) Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Mol Psychiatry 12:544-555.
98. Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Iida H, Noguchi H, Nakabayashi T, Hori H, Ohmori M, Tsukue R, Anami K, Hirabayashi N, Harada S, Arima K, Saitoh O, Kunugi H (2006) The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 129:399-410.
99. Oroszi G, Lapteva L, Davis E, Yarboro CH, Weickert T, Roebuck-Spencer T, Bleiberg J, Rosenstein D, Pao M, Lipsky PE, Goldman D, Lipsky RH, Illei GG (2006) The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neu-rocognitive dysfunction in systemic lupus erythematosus. Ann Rheum Dis 65:1330-1335.
100. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546-1552.
101. Pan JW, Takahashi K (2005) Interdependence of N-acetyl aspartate and high-energy phosphates in healthy human brain. Ann Neurol 57:92-97.
102. Parks MH, Dawant BM, Riddle WR, Hartmann SL, Dietrich MS, Nickel MK, Price RR, Martin PR (2002) Longitudinal brain metabolic characterization of chronic alcoholics with proton magnetic resonance spectroscopy. Alcohol Clin Exp Res 26:1368-1380.
103. Petroff OA, Errante LD, Rothman DL, Kim JH, Spencer DD (2002) Neuro-nal and glial metabolite content of the epileptogenic human hippocampus. Ann Neurol 52:635-642.
104. Polich J, Pollock VE, Bloom FE (1994) Meta-analysis of P300 amplitude from males at risk for alcoholism. Psychol Bull 115:55-73.
105. Pomerleau CS, Aubin HJ, Pomerleau OF (1997) Self-reported alcohol use patterns in a sample of male and female heavy smokers. J Addict Dis 16:19-24.
106. Prendergast MA, Rogers DT, Barron S, Bardo MT, Littleton JM (2002) Ethanol and nicotine: a pharmacologic balancing act? Alcohol Clin Exp Res 26:1917-1918.
107. Ray LA, Hutchison KE (2004) A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28:1789-1795.
108. Roffman JL, Weiss AP, Goff DC, Rauch SL, Weinberger DR (2006) Neuroi-maging-genetic paradigms: a new approach to investigate the pathophysiol-ogy and treatment of cognitive deficits in schizophrenia. Harv Rev Psychiatry 14:78-91.
109. Romberger DJ, Grant K (2004) Alcohol consumption and smoking status: the role of smoking cessation. Biomed Pharmacother 58:77-83.
110. Rose JE, Behm FM, Westman EC, Mathew RJ, London ED, Hawk TC, Tur-kington TG, Coleman RE (2003) PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry 160:323-333.
111. Ross B, Bluml S (2001) Magnetic resonance spectroscopy of the human brain. Anat Rec 265:54-84.
112. Rothman DL, Behar KL, Hyder F, Shulman RG (2003) In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu Rev Physiol 65:401-427.
113. Saint-Cyr JA (2003) Frontal-striatal circuit functions: context, sequence, and consequence. J Int Neuropsychol Soc 9:103-127.
114. Scherk H, Backens M, Schneider-Axmann T, Kraft S, Kemmer C, Usher J, Reith W, Falkai P, Meyer J, Gruber O (2007) Dopamine transporter genotype influences N-acetyl-aspartate in the left putamen. World J Biol Psychiatry Oct 26:1-7, doi:10.1080/15622970701586349. [Epub ahead of print].
115. Schuckit MA (1984) Subjective responses to alcohol in sons of alcoholics and control subjects. Arch Gen Psychiatry 41:879-884.
116. Schuckit MA, Gold EO, Croot K, Finn P, Polich J (1988) P300 latency after ethanol ingestion in sons of alcoholics and in controls. Biol Psychiatry 24:310-315.
117. Schuff N, Ezekeil F, Gamst A, Amend D, Capizzano A, Maudsley A, Weiner M (2001) Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med 45:899-907.
118. Schweinsburg BC, Taylor MJ, Alhassoon OM, Videen JS, Brown GG, Patterson TL, Berger F, Grant I (2001) Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin Exp Res 25:924-934.
119. Schweinsburg BC, Taylor MJ, Videen JS, Alhassoon OM, Patterson TL, Grant I (2000) Elevated myo-inositol in gray matter of recently detoxified but not long-term alcoholics: A preliminary MR spectroscopy study. Alc Clin Exp Res 24:699-770.
120. Seitz D, Widmann U, Seeger U, Nagele T, Klose U, Mann K, Grodd W (1999) Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifing alcoholics. Alcohol Clin Exp Res 23:158-163.
121. Simmons ML, Frondoza CG, Coyle JT (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45: 37-45.
122. Skowronek MH, Laucht M, Hohm E, Becker K, Schmidt MH (2006) Interaction between the dopamine D4 receptor and the serotonin transporter promoter polymorphisms in alcohol and tobacco use among 15-year-olds. Neurogenetics 7:239-246.
123. Starr JM, Fox H, Harris SE, Deary IJ, Whalley LJ (2007) COMT genotype and cognitive ability: a longitudinal aging study. Neurosci Lett 421:57-61.
124. Stoltenberg SF, Mudd SA, Blow FC, Hill EM (1998) Evaluating measures of family history of alcoholism: density versus dichotomy. Addiction 93:1511-1520.
125. Sullivan E (2003) Compromised pontocerebellar and cerebellothalamocortical systems: speculations on their contributions to cognitive and motor impairment in nonamnesic alcoholism. Alcohol Clin Exp Res 27:1409-1419.
126. Sumitani S, Harada M, Kubo H, Ohmori T (2007) Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients. Psychiatry Res 154:85-92.
127. Tarter RE, Alterman AI, Edwards KL (1985) Vulnerability to alcoholism in men: a behavior-genetic perspective. J Stud Alcohol 46:329-356.
128. Taylor DL, Davies SE, Obrenovitch TP, Doheny MH, Patsalos PN, Clark JB, Symon L (1995) Investigation into the role of N-acetylaspartate in cerebral osmoregulation. J Neurochem 65:275-281.
129. Taylor WD, Zuchner S, Payne ME, Messer DF, Doty TJ, MacFall JR, Beyer JL, Krishnan KR (2007) The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults. Psychiatry Res 155:173-177.
130. Tyndale RF (2003) Genetics of alcohol and tobacco use in humans. Ann Med 35:94-121.
131. Uhl GR, Drgon T, Johnson C, Fatusin OO, Liu QR, Contoreggi C, Li CY, Buck K, Crabbe J (2008) "Higher order" addiction molecular genetics: Convergent data from genome-wide association in humans and mice. Biochem Pharmacol 75:98-111.
132. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW (1994) What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? [editorial]. J Neurol 241:354-371.
133. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP (1993) Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177.
134. Volkow ND, Wang GJ, Begleiter H, Porjesz B, Fowler JS, Telang F, Wong C, Ma Y, Logan J, Goldstein R, Alexoff D, Thanos PK (2006) High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry 63:999-1008.
135. van den Wildenberg E, Wiers RW, Dessers J, Janssen RG, Lambrichs EH, Smeets HJ, van Breukelen GJ (2007) A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. Alcohol Clin Exp Res 31:1-10.
136. Wilhelm J, Frieling H, von Ahsen N, Hillemacher T, Kornhuber J, Bleich S (2008) Apolipoprotein E polymorphism, homocysteine serum levels and hip-pocampal volume in patients with alcoholism: an investigation of a gene-environment interaction. Pharmacogenomics J 8:117-121.
137. Wilhelmsen KC, Swan GE, Cheng LS, Lessov-Schlaggar CN, Amos CI, Feiler HS, Hudmon KS, Ring HZ, Andrews JA, Tildesley E, Benowitz NL, Hops H (2005) Support for previously identified alcoholism susceptibility Loci in a cohort selected for smoking behavior. Alcohol Clin Exp Res 29:2108-2115.
138. Winterer G, Goldman D (2003) Genetics of human prefrontal function. Brain Res Brain Res Rev 43:134-163.
139. Zahr NM, Mayer D, Pfefferbaum A, Sullivan EV (2008) Low striatal gluta-mate levels underlie cognitive decline in the elderly: evidence from in vivo molecular spectroscopy. Cereb Cortex Jan 23, doi: 10.1093/cercor/bhm250. [Epub ahead of print].
140. Zinkstok J, Schmitz N, van Amelsvoort T, de Win M, van den Brink W, Baas F, Linszen D (2006) The COMT vall 58met polymorphism and brain mor-phometry in healthy young adults. Neurosci Lett 405:34-39.
141. Zucker RA, Ellis DA, Fitzgerald HE (1994) Developmental evidence for at least two alcoholisms. I. Biopsychosocial variation among pathways into symptomatic difficulty. Ann N Y Acad Sci 708:134-146.